ELAVL1 and invasive ductal breast carcinoma: Coherently, ELAVL1 is more expressed in more aggressive BRCA subtypes, such as the triple negative one, the PAM50 basal subtype, and the invasive ductal carcinomas (Supplementary Fig. 13a–f).